Device evaluation: result - the complaint handling lab received three (3) bd integra syringes.Two (2) sealed and one (1) used bd 25 gaxin integra syringe with needle cat# 305270 lot# 4322824.The two (2) sealed samples were visually inspected no defects were observed.The samples were activated following the step in the ifu and the needles of both samples retracted without an issue.After the medication is completely administered you are to push the plunger rod until you hear two (2) ¿clicks." if you depress the plunger rod and do not hear the ¿clicks¿ the safety mechanism will not activate and the needle will not retract.For the one (1) sample that was returned used, the needle was not attached to the syringe.The plunger rod was fully depressed and the retraction mechanism was activated and the needle (that was not attached to the syringe) was not retracted.This confirms the customer¿s issue of the needle not being retracted and being ejected.In respect to the leakage issue, when a needle does not retract there will be leakage because the fluid in the barrel will escaped through the hole the needle was supposed to retract into.The reported lot# 4322824 was produced in nov 2014.A review of the device history record was performed, no machine adjustments were noted and all visual inspections were performed as per requirement with no quality notifications related to the complaint defect.This lot was inspected and accepted based on meeting our inspection control plan and subsequently approved for shipment.Conclusion - bd was able to confirm the customer's indicated failure.An absolute root cause was not determined.
|